Alkermes (ALKS)
NASDAQ: ALKS
· Real-Time Price · USD
28.92
-1.08 (-3.60%)
At close: Sep 04, 2025, 3:59 PM
28.61
-1.07%
After-hours: Sep 04, 2025, 07:47 PM EDT
Alkermes Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aristada And Aristada Initio Revenue | 101.3M | 244.49M | 96.62M | 84.65M | 86.05M | 78.87M | 247.61M | 80.08M | 79.23M | 74.62M | 72.48M | 78.66M | 68.87M | 72.39M | 55.43M | 148.96M | 142.66M | 130.41M | 129.73M | 138.77M | 136.63M | 99.48M | 83.83M | 79.89M | 76.2M |
| Aristada And Aristada Initio Revenue Growth | -58.57% | +153.06% | +14.13% | -1.62% | +9.10% | -68.15% | +209.22% | +1.07% | +6.17% | +2.95% | -7.85% | +14.21% | -4.86% | +30.60% | -62.79% | +4.42% | +9.39% | +0.53% | -6.52% | +1.57% | +37.35% | +18.67% | +4.93% | +4.84% | n/a |
| L Y B A L V I Revenue | 84.28M | n/a | 76.98M | 74.7M | 71.35M | 57.01M | 153.9M | 37.99M | 34.91M | 20.06M | 13.93M | 178.92M | 157.74M | 160.81M | 129.96M | n/a | n/a | 71.65M | 78.77M | 85.16M | n/a | n/a | n/a | n/a | n/a |
| L Y B A L V I Revenue Growth | n/a | n/a | +3.05% | +4.69% | +25.16% | -62.96% | +305.09% | +8.84% | +74.01% | +44.02% | -92.21% | +13.43% | -1.91% | +23.73% | n/a | n/a | n/a | -9.04% | -7.51% | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue | 307.24M | n/a | 307.73M | 273M | 269.27M | 233.54M | 705.27M | 214.73M | 216.12M | 190.79M | 171.27M | 92.04M | 88.86M | 88.42M | 74.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | n/a | n/a | +12.72% | +1.38% | +15.30% | -66.89% | +228.45% | -0.64% | +13.28% | +11.40% | +86.08% | +3.57% | +0.51% | +18.63% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Vivitrol Revenue | 121.66M | n/a | 134.13M | 113.65M | 111.87M | 97.66M | 303.76M | 96.66M | 101.98M | 96.11M | 84.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Vivitrol Revenue Growth | n/a | n/a | +18.02% | +1.59% | +14.55% | -67.85% | +214.26% | -5.22% | +6.12% | +13.26% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 170.85M | 171.7M | 146.99M | 150.38M | 168.11M | 179.75M | 140.57M | 156.37M | 195.76M | 167.83M | 157.54M | 152.78M | 150.38M | 145.05M | 160.41M | 136.21M | 139.19M | 125.17M | 145.78M | 127.65M | 132.03M | 133.37M | 154.45M | 148.7M | 155.07M | 141.22M | 141.23M | 128.78M | 138.26M | 118.15M | 110.9M | 99.63M | 108.95M | 102.1M | 97.14M | 91.14M | 96.12M | 89.72M | 87.47M | 89.5M | 71.54M | 63.05M |
| Selling, General, and Administrative Revenue Growth | -0.50% | +16.81% | -2.25% | -10.55% | -6.47% | +27.87% | -10.11% | -20.12% | +16.64% | +6.53% | +3.12% | +1.60% | +3.67% | -9.57% | +17.76% | -2.14% | +11.20% | -14.14% | +14.20% | -3.31% | -1.01% | -13.65% | +3.87% | -4.11% | +9.81% | 0.00% | +9.67% | -6.86% | +17.02% | +6.54% | +11.30% | -8.55% | +6.71% | +5.10% | +6.58% | -5.18% | +7.14% | +2.57% | -2.26% | +25.10% | +13.46% | n/a |
| Research and Development Revenue | 77.37M | 71.82M | 56.67M | 59.89M | 59.65M | 67.61M | -20.76M | 64.88M | 68.22M | 63.77M | 104.59M | 100.43M | 92.87M | 95.95M | 98.37M | 118.41M | 97.47M | 92.27M | 112.11M | 94.98M | 94.22M | 93.28M | 198.16M | 107.67M | 104.44M | 102.57M | 108.97M | 101.27M | 106.82M | 108.35M | 104.49M | 104.41M | 99.15M | 104.83M | 89.63M | 99.44M | 97.01M | 101.07M | 93.69M | 92.56M | 87.88M | 70.28M |
| Research and Development Revenue Growth | +7.73% | +26.72% | -5.37% | +0.41% | -11.78% | -425.69% | -132.00% | -4.91% | +6.99% | -39.03% | +4.14% | +8.14% | -3.21% | -2.46% | -16.92% | +21.48% | +5.64% | -17.70% | +18.03% | +0.80% | +1.01% | -52.93% | +84.04% | +3.10% | +1.82% | -5.87% | +7.61% | -5.20% | -1.41% | +3.69% | +0.08% | +5.30% | -5.42% | +16.97% | -9.87% | +2.51% | -4.02% | +7.88% | +1.22% | +5.32% | +25.05% | n/a |
| Sales and Marketing Revenue | 121.17M | 122.93M | 98.81M | 102.1M | 119.7M | 125.6M | 116.3M | 114.8M | 137.9M | 118.5M | n/a | 96.9M | 95.3M | 96.2M | n/a | 88M | 85.7M | 79.7M | n/a | 79M | 82.9M | 87.8M | n/a | n/a | n/a | 90.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -1.43% | +24.41% | -3.22% | -14.70% | -4.70% | +8.00% | +1.31% | -16.75% | +16.37% | n/a | -100.00% | +1.68% | -0.94% | n/a | -100.00% | +2.68% | +7.53% | n/a | -100.00% | -4.70% | -5.58% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |